Clinical Trials
3 trialsNCT07269470 2026-05-05
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT07091019 2025-07-29
ASC4REAL-2
Novartis
Not yet recruiting
NCT05944783 2025-02-12
BE-Dasatinib
Centro de Atencion e Investigacion Medica
Phase 4 Not yet recruiting